CD4 and tuberculosis: Another study showed that LTBI patients but not healthy or BCG-vaccinated individuals after TB treatment presented a CD4 cell subset, which was CD27-PC-1+, and demonstrated that Mtb antigens caused in vivo cell differentiation, which raises the possibility of these membrane markers being used to distinguish between people who have LTBI and healthy people, as well as to track the effectiveness of TB medication [104].